Asthma

Otolaryngologic Clinics of North America

Volumn 44, Issue 3, 2011, Pages 667-684

  Parker, Michael J ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Airway inflammation; Allergens; Asthma; Asthma diagnosis; Asthma management; Asthma symptoms; Genetic risk; Hyperresponsiveness

Indexed keywords

AUTACOID; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; LEUKOTRIENE RECEPTOR BLOCKING AGENT; NEDOCROMIL; OMALIZUMAB; SALBUTAMOL; THEOPHYLLINE; ZILEUTON;

ANAMNESIS; ASTHMA; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDICATION; DRUG MEGADOSE; HUMAN; IMMUNOPATHOLOGY; LOW DRUG DOSE; LUNG FUNCTION TEST; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; SYMPTOM;

ASTHMA; BRONCHIAL PROVOCATION TESTS; HUMANS; PATIENT EDUCATION AS TOPIC; RESPIRATORY FUNCTION TESTS; RHINITIS, ALLERGIC, PERENNIAL; RISK FACTORS;

EID: 79957493829     PISSN: 00306665     EISSN: 15578259     Source Type: Journal    
DOI: 10.1016/j.otc.2011.04.001     Document Type: Review

References (40)

1. Slavin R.G. The upper and lower airways: the epidemiological and pathophysiological connection. Allergy Asthma Proc 2008, 29:553.
2. Greenberger P.A. Allergic rhinitis and asthma connection: treatment implications. Allergy Asthma Proc 2008, 29:557.
3. Sibbald B., Rink E. Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history. Thorax 1991, 46:895.
4. National Health Interview Survey (NHIS 2005) 2005, National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention, Hyattsville (MD), Available at:, Accessed August 28, 2010 and September 27, 2010. http://www.cdc.gov/nchs/fastats/asthma.htm.
5. Eichenfield L.F., Hanifin J.M., Beck L.A., et al. Atopic dermatitis and asthma: parallels in the evolution of treatment. Pediatrics 2003, 111(3):608-616.
6. Leynaert B., Bousquet J., Neukirch C., et al. Perennial rhinitis: an independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 1999, 104:301.
7. Zimmermann N., Hershey G.K., Foster P.S., et al. Chemokines in asthma: cooperative interaction between chemokines and IL-13. J Allergy Clin Immunol 2003, 111(2):227-242.
8. Busse W.W. The role of leukotrienes in asthma and allergic rhinitis [review]. Clin Exp Allergy 1996, 26(8):868-879.
9. Deykin A., Massaro A.F., Drazen J.M., et al. Exhaled nitric oxide as a diagnostic test for asthma: online versus offline techniques and effect of flow rate. Am J Respir Crit Care Med 2002, 165(12):1597-1601.
10. Boyce J.A. Mast cells: beyond IgE. J Allergy Clin Immunol 2003, 111(1):24-32. [quiz: 33].
11. Cohn L., Elias J.A., Chupp G.L. Asthma: mechanisms of disease [review]. Annu Rev Immunol 2004, 22:789-815.
12. Allen M., Heinzmann A., Noguchi E., et al. Positional cloning of a novel gene influencing asthma from chromosome 2q14. Nat Genet 2003, 35:258.
13. Arbes S.J., Gergen P.J., Vaughn B., et al. Asthma cases attributable to atopy: results from the Third National Health and Nutrition Examination Survey. J Allergy Clin Immunol 2007, 120:1139.
14. Johnston S.L., Pattemore P.K., Sanderson G., et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995, 310:1225.
15. Cunningham J., O'Connor G.T., Dockery D.W., et al. Environmental tobacco smoke, wheezing, and asthma in children in 24 communities. Am J Respir Crit Care Med 1996, 153:218.
16. Beuther D.A., Sutherland E.R. Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med 2007, 175:661.
17. Guilbert T.W., Morgan W.J., Zeiger R.S., et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006, 354(19):1985-1997.
18. Dijkstra A., Vonk J.M., Jongepier H., et al. Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex. Thorax 2006, 61(2):105-110.
19. Lange P., Scharling H., Ulrik C.S., et al. Inhaled corticosteroids and decline of lung function in community residents with asthma. Thorax 2006, 61(2):100-104.
20. Childhood Asthma Management Program Research Group (CAMP). Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000, 343(15):1054-1063.
21. Pratter M.R., Hingston D.M., Irwin R.S. Diagnosis of bronchial asthma by clinical evaluation. An unreliable method. Chest 1983, 84:42.
22. Irwin R.S., Curley F.J., French C.L. Chronic cough. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Am Rev Respir Dis 1990, 141:640.
23. Pratter M.R., Curley F.J., Dubois J., et al. Cause and evaluation of chronic dyspnea in a pulmonary disease clinic. Arch Intern Med 1989, 149:2277.
24. Juniper E.F., O'Byrne P.M., Guyatt G.H., et al. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999, 14:902.
25. Vollmer W.M., Markson L.E., O'Connor E., et al. Association of asthma control with health care utilization and quality of life. Am J Respir Crit Care Med 1999, 160:1647.
26. Boulet L.P., Boulet V., Milot J. How should we quantify asthma control? A proposal. Chest 2002, 122:2217.
27. Nathan R.A., Sorkness C.A., Kosinski M., et al. Development of the Asthma Control Test: a survey for assessing asthma control. J Allergy Clin Immunol 2004, 113:59.
28. Patino C.M., Okelo S.O., Rand C.S., et al. The asthma control and communication instrument: a clinical tool developed for ethnically diverse populations. J Allergy Clin Immunol 2008, 122:936.
29. Schatz M., Kosinski M., Yarlas A.S., et al. The minimally important difference of the Asthma Control Test. J Allergy Clin Immunol 2009, 124:719.
30. Liu A.H., Zeiger R.S., Sorkness C.A., et al. The Childhood Asthma Control Test: retrospective determination and clinical validation of a cut point to identify children with very poorly controlled asthma. J Allergy Clin Immunol 2010, 126:267.
31. Bateman E.D., Reddel H.K., Eriksson G., et al. Overall asthma control: the relationship between current control and future risk. J Allergy Clin Immunol 2010, 125:600.
32. National Asthma Education and Prevention Program: Expert Panel Report III: guidelines for the diagnosis and management of asthma 2007, National Heart, Lung, and Blood Institute, Bethesda (MD), (NIH publication no. 08-4051). Available at:, Accessed September 27, 2010. http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm.
33. Klemets P., Lyytikäinen O., Ruutu P., et al. Risk of invasive pneumococcal infections among working age adults with asthma. Thorax 2010, 65:698.
34. Nelson H.S. Beta-adrenergic bronchodilators. N Engl J Med 1995, 333:499.
35. Haahtela T., Järvinen M., Kava T., et al. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 1991, 325:388.
36. Dutoit J.I., Salome C.M., Woolcock A.J. Inhaled corticosteroids reduce the severity of bronchial hyperresponsiveness in asthma but oral theophylline does not. Am Rev Respir Dis 1987, 136:1174.
37. Juniper E.F., Kline P.A., Vanzieleghem M.A., et al. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis 1990, 142:832.
38. Chowdhury B.A., Dal Pan G. The FDA and safe use of long-acting beta-agonists in the treatment of asthma. N Engl J Med 2010, 362:1169.
39. FDA drug safety communication: new safety requirements for long-acting inhaled medications called long-acting beta-agonists (LABAs) Available at:, Accessed September 05, 2010. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm200776.htm.
40. Bateman E.D., Bousquet J., Keech M.L., et al. The correlation between asthma control and health status: the GOAL study. Eur Respir J 2007, 29:56.